期刊文献+

血液净化联合前列地尔及奥曲肽治疗高脂血症胰腺炎的临床研究 被引量:6

Clinical Research of CBP and Alprostadil and Octreotide Acetate Treatment of Hyperlipoidemia Acute Pancreatit
下载PDF
导出
摘要 目的研究血液净化(continuous blood purification,CBP)联合前列地尔注射液及醋酸奥曲肽治疗高脂血症胰腺炎的疗效。方法 50例高脂血症胰腺炎患者分成观察组和对照组。对照组:醋酸奥曲肽;观察组:醋酸奥曲肽+前列地尔注射液+CBP。结果观察组显效率(80.00%)、总有效率(96.00%)高于对照组显效率为(48.00%)、总有效率(68.00%),差异有统计学意义(P<0.05);观察组治疗5d后血淀粉酶阴转率为80.00%高于对照组血淀粉酶阴转率48.00%,差异有统计学意义(P<0.05)。两组不良反应发生率差异无显著性(P>0.05)。结论 CBP联合前列地尔注射液及醋酸奥曲肽治疗高脂血症胰腺炎疗效可靠,安全,值得临床应用推广。 Objective To study the efficacy research of CBP and alprostadil and octreotide acetate treatment of hyperlipoidemia acute pancreatit. Methods All 50 cases of hyperlipoidemia acute pancreatit were divided into observation group and control group. Control group: octreotide acetate; Observer Group: octreotide acetate + alprostadil+ CBP. Results Significant efficiency of the observation group 80.00%, the total effective 96.00% bigger than significant efficiency 48.00% the total effective 68.00% of control group, difference was statistically significant (P 〈 0.05 ); Treatment for five days, blood amylase yin turn rate the observation group 80.00% than 48.00% in control group, there was statistically significant difference (P 〈 0.05 ). Two groups adverse reactionrate had no significant difference (P 〉 0.05 ). Conclusion CBP and alprostadil and octreotide acetate treatment of hyperlipoidemia acute pancreatit is good efficacy, few adverse reactions, affordable, worth of clinic application promotion.
出处 《中国现代医生》 2011年第24期95-96,共2页 China Modern Doctor
关键词 血液净化 前列地尔 醋酸奥曲肽 高脂血症胰腺炎 CBP Alprostadil Octreotide acetate Hyperlipoidemia acute pancreatit
  • 相关文献

参考文献6

二级参考文献25

共引文献1805

同被引文献36

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部